ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 639617 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 639617; 2) Community: the network communities that were significantly associated with the response to NSC 639617; 3) Molecule: the relationships between components within communities and NSC 639617; 4) MDR: the compounds that were significantly associated with the NSC 639617.

NSC Compound Enrichment Correlation
NSC 700549 8-Quinolinone, 2-chloro-5,6,7,8-tetrahydro-7-(phenylmethylene)- 0.00352002370824893 0.4754837
NSC 704565 Null 0.00352002370824893 0.51053753
NSC 708049 Piperazine-2,2,5,5-tetracarbonitrile, 3,6-dipropyl- 0.00352002370824893 0.63965175
NSC 710204 Null 0.00352002370824893 0.52928767
NSC 727049 11-(6'-Aminohexylidene]-5,6-dihydro-5-keto-2,3-dimethoxy-6-m ethyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.00352002370824893 0.458119
NSC 732841 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3-trifluoromethylbenzene 0.00352002370824893 0.46423062
NSC 758662 Lovastatin [USAN] 0.00352002370824893 -0.18628566
NSC 625731 Null 0.00407837248037202 0.51650068
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.00407837248037202 -0.42334695
NSC 644651 Null 0.00407837248037204 0.66810858
Total:72  Current:10    [First] [Prev] [Next] [Last]